NCT04213209
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Takeda Selected Site Tokyo, Japan
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT04213209
NCT03788291
NCT03016013
NCT02939183
NCT05101759
NCT02532257
NCT02388490
NCT00004112
NCT02892383
NCT00700258